The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Outcomes of patients with malignant pleural mesothelioma (MPM) following the approval cisplatin/pemetrexed: Experience of a comprehensive cancer center.
Deepa Jagtap
No relevant relationships to disclose
Harvey Pass
No relevant relationships to disclose
Frank Baciewicz
No relevant relationships to disclose
Antoinette J. Wozniak
No relevant relationships to disclose
Miguel Alvelo-Rivera
No relevant relationships to disclose
Andre A. Konski
No relevant relationships to disclose
Wei Chen
No relevant relationships to disclose
Daryn W. Smith
No relevant relationships to disclose
Shirish M. Gadgeel
No relevant relationships to disclose